The CDC Foundation launched the first educational tool using virtual human technology to improve patient-provider conversations about a side effect of chemotherapy that may increase infection risk, known as neutropenia.
The CDC Foundation and Amgen announced several new initiatives that will be available this summer as part of the Preventing Infections in Cancer Patients (PICP) program. The PICP program has been supported by Amgen and led by the Centers for Disease Control and Prevention (CDC) and the CDC Foundation since the program’s launch in 2009.